Global Somatostatin Receptor Type 4 Market Research Report 2021

1 Somatostatin Receptor Type 4 Market Overview
1.1 Product Overview and Scope of Somatostatin Receptor Type 4
1.2 Somatostatin Receptor Type 4 Segment by Type
1.2.1 Global Somatostatin Receptor Type 4 Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 CNTX-0290
1.2.3 NNC-26910
1.2.4 Veldoreotide
1.2.5 Others
1.3 Somatostatin Receptor Type 4 Segment by Application
1.3.1 Somatostatin Receptor Type 4 Sales Comparison by Application: (2021-2027)
1.3.2 Alzheimer's Disease
1.3.3 Cognitive Disorders
1.3.4 Neuroendocrine Tumors
1.3.5 Acromegally
1.3.6 Others
1.4 Global Somatostatin Receptor Type 4 Market Size Estimates and Forecasts
1.4.1 Global Somatostatin Receptor Type 4 Revenue 2016-2027
1.4.2 Global Somatostatin Receptor Type 4 Sales 2016-2027
1.4.3 Somatostatin Receptor Type 4 Market Size by Region: 2016 Versus 2021 Versus 2027

2 Somatostatin Receptor Type 4 Market Competition by Manufacturers
2.1 Global Somatostatin Receptor Type 4 Sales Market Share by Manufacturers (2016-2021)
2.2 Global Somatostatin Receptor Type 4 Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Somatostatin Receptor Type 4 Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Somatostatin Receptor Type 4 Manufacturing Sites, Area Served, Product Type
2.5 Somatostatin Receptor Type 4 Market Competitive Situation and Trends
2.5.1 Somatostatin Receptor Type 4 Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Somatostatin Receptor Type 4 Players Market Share by Revenue
2.5.3 Global Somatostatin Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Somatostatin Receptor Type 4 Retrospective Market Scenario by Region
3.1 Global Somatostatin Receptor Type 4 Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Somatostatin Receptor Type 4 Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Somatostatin Receptor Type 4 Market Facts & Figures by Country
3.3.1 North America Somatostatin Receptor Type 4 Sales by Country
3.3.2 North America Somatostatin Receptor Type 4 Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Somatostatin Receptor Type 4 Market Facts & Figures by Country
3.4.1 Europe Somatostatin Receptor Type 4 Sales by Country
3.4.2 Europe Somatostatin Receptor Type 4 Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Somatostatin Receptor Type 4 Market Facts & Figures by Region
3.5.1 Asia Pacific Somatostatin Receptor Type 4 Sales by Region
3.5.2 Asia Pacific Somatostatin Receptor Type 4 Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Somatostatin Receptor Type 4 Market Facts & Figures by Country
3.6.1 Latin America Somatostatin Receptor Type 4 Sales by Country
3.6.2 Latin America Somatostatin Receptor Type 4 Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Somatostatin Receptor Type 4 Market Facts & Figures by Country
3.7.1 Middle East and Africa Somatostatin Receptor Type 4 Sales by Country
3.7.2 Middle East and Africa Somatostatin Receptor Type 4 Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Somatostatin Receptor Type 4 Historic Market Analysis by Type
4.1 Global Somatostatin Receptor Type 4 Sales Market Share by Type (2016-2021)
4.2 Global Somatostatin Receptor Type 4 Revenue Market Share by Type (2016-2021)
4.3 Global Somatostatin Receptor Type 4 Price by Type (2016-2021)

5 Global Somatostatin Receptor Type 4 Historic Market Analysis by Application
5.1 Global Somatostatin Receptor Type 4 Sales Market Share by Application (2016-2021)
5.2 Global Somatostatin Receptor Type 4 Revenue Market Share by Application (2016-2021)
5.3 Global Somatostatin Receptor Type 4 Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Crinetics Pharmaceuticals Inc
6.1.1 Crinetics Pharmaceuticals Inc Corporation Information
6.1.2 Crinetics Pharmaceuticals Inc Description and Business Overview
6.1.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Crinetics Pharmaceuticals Inc Product Portfolio
6.1.5 Crinetics Pharmaceuticals Inc Recent Developments/Updates
6.2 Strongbridge Biopharma plc
6.2.1 Strongbridge Biopharma plc Corporation Information
6.2.2 Strongbridge Biopharma plc Description and Business Overview
6.2.3 Strongbridge Biopharma plc Somatostatin Receptor Type 4 Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Strongbridge Biopharma plc Product Portfolio
6.2.5 Strongbridge Biopharma plc Recent Developments/Updates

7 Somatostatin Receptor Type 4 Manufacturing Cost Analysis
7.1 Somatostatin Receptor Type 4 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Somatostatin Receptor Type 4
7.4 Somatostatin Receptor Type 4 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Somatostatin Receptor Type 4 Distributors List
8.3 Somatostatin Receptor Type 4 Customers

9 Somatostatin Receptor Type 4 Market Dynamics
9.1 Somatostatin Receptor Type 4 Industry Trends
9.2 Somatostatin Receptor Type 4 Growth Drivers
9.3 Somatostatin Receptor Type 4 Market Challenges
9.4 Somatostatin Receptor Type 4 Market Restraints

10 Global Market Forecast
10.1 Somatostatin Receptor Type 4 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Somatostatin Receptor Type 4 by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Somatostatin Receptor Type 4 by Type (2022-2027)
10.2 Somatostatin Receptor Type 4 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Somatostatin Receptor Type 4 by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Somatostatin Receptor Type 4 by Application (2022-2027)
10.3 Somatostatin Receptor Type 4 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Somatostatin Receptor Type 4 by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Somatostatin Receptor Type 4 by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Somatostatin Receptor Type 4 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Somatostatin Receptor Type 4 Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Somatostatin Receptor Type 4 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Somatostatin Receptor Type 4 Covered in This Study
Table 5. Global Somatostatin Receptor Type 4 Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Somatostatin Receptor Type 4 Sales Share by Manufacturers (2016-2021)
Table 7. Global Somatostatin Receptor Type 4 Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Somatostatin Receptor Type 4 Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Somatostatin Receptor Type 4 Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Somatostatin Receptor Type 4 Manufacturing Sites and Area Served
Table 11. Manufacturers Somatostatin Receptor Type 4 Product Type
Table 12. Global Somatostatin Receptor Type 4 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Somatostatin Receptor Type 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin Receptor Type 4 as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Somatostatin Receptor Type 4 Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Somatostatin Receptor Type 4 Sales Market Share by Region (2016-2021)
Table 17. Global Somatostatin Receptor Type 4 Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Somatostatin Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Somatostatin Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 20. North America Somatostatin Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Somatostatin Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 22. Europe Somatostatin Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Somatostatin Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 24. Europe Somatostatin Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Somatostatin Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Somatostatin Receptor Type 4 Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Somatostatin Receptor Type 4 Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Somatostatin Receptor Type 4 Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Somatostatin Receptor Type 4 Revenue Market Share by Region (2016-2021)
Table 30. Latin America Somatostatin Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Somatostatin Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 32. Latin America Somatostatin Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Somatostatin Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Somatostatin Receptor Type 4 Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Somatostatin Receptor Type 4 Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Somatostatin Receptor Type 4 Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Somatostatin Receptor Type 4 Revenue Market Share by Country (2016-2021)
Table 38. Global Somatostatin Receptor Type 4 Sales (K Pcs) by Type (2016-2021)
Table 39. Global Somatostatin Receptor Type 4 Sales Market Share by Type (2016-2021)
Table 40. Global Somatostatin Receptor Type 4 Revenue (Million US$) by Type (2016-2021)
Table 41. Global Somatostatin Receptor Type 4 Revenue Share by Type (2016-2021)
Table 42. Global Somatostatin Receptor Type 4 Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Somatostatin Receptor Type 4 Sales (K Pcs) by Application (2016-2021)
Table 44. Global Somatostatin Receptor Type 4 Sales Market Share by Application (2016-2021)
Table 45. Global Somatostatin Receptor Type 4 Revenue (Million US$) by Application (2016-2021)
Table 46. Global Somatostatin Receptor Type 4 Revenue Share by Application (2016-2021)
Table 47. Global Somatostatin Receptor Type 4 Price (USD/Pcs) by Application (2016-2021)
Table 48. Crinetics Pharmaceuticals Inc Corporation Information
Table 49. Crinetics Pharmaceuticals Inc Description and Business Overview
Table 50. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Product
Table 52. Crinetics Pharmaceuticals Inc Recent Developments/Updates
Table 53. Strongbridge Biopharma plc Corporation Information
Table 54. Strongbridge Biopharma plc Description and Business Overview
Table 55. Strongbridge Biopharma plc Somatostatin Receptor Type 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Strongbridge Biopharma plc Somatostatin Receptor Type 4 Product
Table 57. Strongbridge Biopharma plc Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Somatostatin Receptor Type 4 Distributors List
Table 61. Somatostatin Receptor Type 4 Customers List
Table 62. Somatostatin Receptor Type 4 Market Trends
Table 63. Somatostatin Receptor Type 4 Growth Drivers
Table 64. Somatostatin Receptor Type 4 Market Restraints
Table 65. Global Somatostatin Receptor Type 4 Sales Forecast by Type (2022-2027) & (K Pcs)
Table 66. Global Somatostatin Receptor Type 4 Sales Market Share Forecast by Type (2022-2027)
Table 67. Global Somatostatin Receptor Type 4 Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 68. Global Somatostatin Receptor Type 4 Revenue Market Share Forecast by Type (2022-2027)
Table 69. Global Somatostatin Receptor Type 4 Sales Forecast by Application (2022-2027) & (K Pcs)
Table 70. Global Somatostatin Receptor Type 4 Sales Market Share Forecast by Application (2022-2027)
Table 71. Global Somatostatin Receptor Type 4 Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 72. Global Somatostatin Receptor Type 4 Revenue Market Share Forecast by Application (2022-2027)
Table 73. Global Somatostatin Receptor Type 4 Sales Forecast by Region (2022-2027) & (K Pcs)
Table 74. Global Somatostatin Receptor Type 4 Sales Market Share Forecast by Region (2022-2027)
Table 75. Global Somatostatin Receptor Type 4 Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 76. Global Somatostatin Receptor Type 4 Revenue Market Share Forecast by Region (2022-2027)
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Somatostatin Receptor Type 4
Figure 2. Global Somatostatin Receptor Type 4 Market Share by Type in 2020 & 2027
Figure 3. CNTX-0290 Product Picture
Figure 4. NNC-26910 Product Picture
Figure 5. Veldoreotide Product Picture
Figure 6. Others Product Picture
Figure 7. Global Somatostatin Receptor Type 4 Market Share by Application in 2020 & 2027
Figure 8. Alzheimer's Disease
Figure 9. Cognitive Disorders
Figure 10. Neuroendocrine Tumors
Figure 11. Acromegally
Figure 12. Others
Figure 13. Global Somatostatin Receptor Type 4 Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Somatostatin Receptor Type 4 Market Size 2016-2027 (US$ Million)
Figure 15. Global Somatostatin Receptor Type 4 Sales 2016-2027 (K Pcs)
Figure 16. Global Somatostatin Receptor Type 4 Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Somatostatin Receptor Type 4 Sales Share by Manufacturers in 2020
Figure 18. Global Somatostatin Receptor Type 4 Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Somatostatin Receptor Type 4 Players: Market Share by Revenue in 2020
Figure 20. Somatostatin Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Somatostatin Receptor Type 4 Sales Market Share by Region (2016-2021)
Figure 22. Global Somatostatin Receptor Type 4 Sales Market Share by Region in 2020
Figure 23. Global Somatostatin Receptor Type 4 Revenue Market Share by Region (2016-2021)
Figure 24. Global Somatostatin Receptor Type 4 Revenue Market Share by Region in 2020
Figure 25. U.S. Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Somatostatin Receptor Type 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Somatostatin Receptor Type 4 by Type (2016-2021)
Figure 50. Sales Market Share of Somatostatin Receptor Type 4 by Application (2016-2021)
Figure 51. Sales Market Share of Somatostatin Receptor Type 4 by Application in 2020
Figure 52. Revenue Share of Somatostatin Receptor Type 4 by Application (2016-2021)
Figure 53. Revenue Share of Somatostatin Receptor Type 4 by Application in 2020
Figure 54. Manufacturing Cost Structure of Somatostatin Receptor Type 4
Figure 55. Manufacturing Process Analysis of Somatostatin Receptor Type 4
Figure 56. Somatostatin Receptor Type 4 Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.